Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Calreticulin polyclonal antibody

ALX-210-126-R100 100 µl 656.00 USD
Do you need bulk/larger quantities?

Product Details

Immunogen:Recombinant human calreticulin.
UniProt ID:P27797
Species reactivity:Human, Mouse, Rat
Dog, Monkey, Rabbit
Applications:Flow Cytometry, ICC, IHC, IP, WB
Recommended Dilutions/Conditions:Immunohistochemistry (1:100)
Western Blot (1:1,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Formulation:Liquid. Antiserum containing 0.05% sodium azide.
Handling:Avoid freeze/thaw cycles.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Regulatory Status:RUO - Research Use Only
Calreticulin polyclonal antibody IHC
Figure: Immunolocalization of calreticulin in rat brain cortex using PAb to calreticulin (Prod. No. ALX-210-126)."
Please mouse over
Calreticulin polyclonal antibody IHC

Product Literature References

Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin: A. Otteken & B. Moss; J. Biol. Chem. 271, 97 (1996), Abstract; Full Text
Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading: T.K. White, et al.; J. Biol. Chem. 270, 15926 (1995), Abstract; Full Text
Redistribution of intracellular Ca2+ stores during phagocytosis in human neutrophils: O. Stendahl, et al.; Science 265, 1439 (1994), Abstract;

Related Products

Calreticulin (NT) polyclonal antibody 

ICC, WB | Print as PDF
ALX-210-170-R100 100 µl 476.00 USD
Do you need bulk/larger quantities?

Related Literature

Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2022 Enzo Life Sciences, Inc.,